Amniotic fluid embolism: the complication of known pathomechanism but without pathogenetic therapy?
Uszynski
Mieczyslaw
M
D000653:Amniotic Fluid / Q000166:cytology / Q000201:enzymology / Q000378:metabolism*; D000925:Anticoagulants / Q000627:therapeutic use; D001777:Blood Coagulation; D004211:Disseminated Intravascular Coagulation / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy; D004619:Embolism, Amniotic Fluid / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy; D015951:Factor Xa / Q000378:metabolism; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D010718:Phosphatidylserines / Q000378:metabolism*; D011247:Pregnancy; D011516:Prothrombin / Q000378:metabolism; D013925:Thromboplastin / Q000378:metabolism*
D000925:Anticoagulants; D010718:Phosphatidylserines; D011516:Prothrombin; D006493:Heparin; D013925:Thromboplastin; D015951:Factor Xa